India outlines draft recall guidelines amid concerns over implementation challenges
This article was originally published in SRA
Executive Summary
India's proposed first-time structured recall guidelines for drugs including biologicals and vaccines are seen as much overdue, but some experts say that implementation aspects may pose challenges given the large number of players across the chain in the industry1.